Pregnancy and primary pulmonary hypertension: Successful outcome with epoprostenol therapy

Rosalyn Stewart, Divina Tuazon, Gayle Olson, Alexander G. Duarte

Research output: Contribution to journalArticlepeer-review

81 Scopus citations


Primary pulmonary hypertension (PPH) associated with pregnancy carries a high maternal mortality rate. Short-term epoprostenol infusion has been demonstrated to improve the hemodynamic profile in patients with PPH. We report a successful maternal-fetal outcome with epoprostenol therapy during pregnancy, cesarean section, and postpartum in a patient with PPH. Epoprostenol therapy did not produce any physical or developmental abnormalities in the fetus. A favorable maternal-fetal outcome may occur with a multidisciplinary approach.

Original languageEnglish (US)
Pages (from-to)973-975
Number of pages3
Issue number3
StatePublished - 2001


  • Cesarean section
  • Epoprostenol
  • Pregnancy
  • Pulmonary hypertension

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Pregnancy and primary pulmonary hypertension: Successful outcome with epoprostenol therapy'. Together they form a unique fingerprint.

Cite this